Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension

BACKGROUND: Recent studies have revealed that sustained ingestion of angiotensin converting enzymes inhibitors or angiotensin receptor blockers (ACEIs/ARBs) had no harmful effects on coronavirus disease 2019 (COVID-19) patients complicated with hypertension. AIM: To investigate the impact on COVID-1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Clin Cases
Main Authors: Tian, Ci, Li, Nan, Bai, Yi, Xiao, Han, Li, Shu, Ge, Qing-Gang, Shen, Ning, Ma, Qing-Bian
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2021
Assuntos:
Retrospective Cohort Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7809663/
https://ncbi.nlm.nih.gov/pubmed/33511171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v9.i1.47
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados